German Registry for Transcatheter Tricuspid Valve Interventions

All-cause death and heart failure hospitalisation

All-cause death and heart failure hospitalisation 1 year after transcatheter tricuspid valve treatment (TTVT)

All-cause death and heart failure hospitalisation (long-term)

Long-term all-cause death and heart failure hospitalisation after transcatheter tricuspid valve treatment (TTVT)

All-cause death and heart failure hospitalisation (short-term)

Short-term all-cause death and heart failure hospitalisation after transcatheter tricuspid valve treatment (TTVT)

Change of tricuspid regurgitation after transcatheter tricuspid valve treatment (TTVT)

Assessed by echocardiography, tricuspid regurgitation graded on a 4-grade scale.

Change of cardiopulmonal symptoms after transcatheter tricuspid valve treatment (TTVT)

Assessment for cardiopulmonal symptoms include edema scaling

Safety outcome after transcatheter tricuspid valve treatment (TTVT)

The saftety outcome contains all complications which occur between the interventional treatment of the tricuspid regurgitation and discharge from the hospital. Data collection includes: mortality with differentiation of cardiac death and non-cardiac death, unplanned cardiac surgery, re-intervention of tricuspid valve, pericardial tamponade, intervention of coronary arteries. Moreover major adverse events as defined by MVARC2 criteria are recorded at discharge from hospital: death with differentiation of cardiac death and non-cardiac death, peri-procedural or spontaneous myocardial infarction, stroke, transient ischemic attack, life-threatening, major or minor bleeding, acute kidney failure, complications of the vascular access.